
Qing Li Peptide
Finnrick has tested 296 samples from Qing Li Peptide across 13 products.
Finnrick Vendor Profile
to
Qing Li Peptide
Tracking 13 products
296 total samples tested
Last test 19 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| PT-141 | 6 | 31 Jul 2025 | 18 Mar 2026 | |||||
| Survodutide | 3 | 14 Jul 2025 | 3 Oct 2025 | |||||
| Cagrilintide | 4 | 9 Jul 2025 | 6 Mar 2026 | |||||
| CJC-1295 | 17 | 10 Jun 2025 | 7 Mar 2026 | |||||
| GHK-Cu | 31 | 10 Jul 2025 | 18 Mar 2026 | |||||
| Melanotan II | 7 | 18 Jul 2025 | 13 Mar 2026 | |||||
| Sermorelin | 5 | 18 Sep 2025 | 30 Dec 2025 | |||||
| BPC-157 | 29 | 11 Jun 2025 | 18 Mar 2026 | |||||
| Ipamorelin | 14 | 10 Jun 2025 | 7 Mar 2026 | |||||
| Retatrutide | 106 | 9 Jun 2025 | 19 Mar 2026 | |||||
| TB-500 | 16 | 29 Jun 2025 | 18 Mar 2026 | |||||
| Tesamorelin | 19 | 29 Jun 2025 | 18 Mar 2026 | |||||
| Tirzepatide | 39 | 3 Jul 2025 | 18 Mar 2026 | |||||
The Qing Li Peptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.7
Based on 46 overall satisfaction reports
Ease of Purchase4.7(46)
Payment Methods4.5(46)
Delivery Speed4.4(46)
Packaging Quality4.8(46)
Customer Service4.9(45)
People who submitted test requests to Finnrick gave Qing Li Peptide an average satisfaction rating of 4.7 out of 5 across 46 reports associated with samples received and tested by Finnrick.
Most recent Qing Li Peptide tests
Samples are tested in commercial labs
296
tests
13
products
Scores
AVGMINMAX
First
9 Jun 2025
Last
19 Mar 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 19 Mar 2026 | Retatrutide | View | 20mg | 21.4mg | +7.0% | 99.90% | Feb 2, 2026 | White Label / Gold Crimp / Clear Cap | Lab E | Public | |
| 19 Mar 2026 | Retatrutide | View | 15mg | 15.3mg | +2.0% | 99.90% | RT15-010226 | White Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 18 Mar 2026 | GHK-Cu | View | 50mg | 41.7mg | -16.6% | 99.90% | October 16,2025 | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 18 Mar 2026 | Tesamorelin | View | 10mg | 8.84mg | -11.6% | 98.50% | October 9, 2027 | White Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 18 Mar 2026 | Retatrutide | View | 20mg | 18.1mg | -9.5% | 99.90% | 2/5/26 | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 18 Mar 2026 | Tirzepatide | View | 40mg | 46mg | +15.0% | 99.90% | October 2,2025 | White Label / Silver Crimp / Clear Green Cap | Lab E | Public | |
| 18 Mar 2026 | PT-141 | View | 10mg | 11mg | +10.0% | 99.70% | October 2,2025 | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
Corrections
- 25 Jul 2025:
- Qing Li Peptides print a manufacturing date on their kit boxes. We consider this an equivalent to a batch ID, as it is clearly printed on the packaging and available for the public. When samples are submitted by the public, this identifier was not always collected, affecting test scores. This data may be collected in the future, resulting in an updated test score, and Finnrick Rating.